CAS 186497-38-1

ZD-1611

CAS : 186497-38-1

ZD-1611 is a monoclonal antibody that targets endothelin-a receptor and has been shown to be effective in treating solid tumours. It blocks the binding of endothelin-a to its receptors, thereby inhibiting the growth factor signalling pathway. ZD-1611 also has an effect on the b-raf and atherosclerotic cardiovascular systems, which may be due to its ability to inhibit growth factors such as IGF-I. The anti-cancer properties of ZD-1611 are mediated through various mechanisms including complementarity with cancer cells, inhibition of cancer cell proliferation, and induction of apoptosis.

Formule : C₂₂H₂₄N₄O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 456.5 g/mol

Ref: 3D-LHA49738

ZD-1611

CAS : 186497-38-1

ZD-1611 is an effective and selective ETA receptor antagonist. It is used for the research of ischemic stroke.

Formule : C₂₂H₂₄N₄O₅S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 456.51

Ref: TM-T17287